AstraZeneca AZN reported strong U.S. phase 3 data for its COVID-19 vaccine, AZD1222. We don't expect any changes to our fair value estimate based on the favorable data, however, since the firm plans ...
FRANKFURT (Reuters) - Germany's influential vaccine advisory panel said on Thursday all infants in the country should receive AstraZeneca and Sanofi's antibody therapy to protect them against the ...
The Oxford-AstraZeneca vaccine was a critical part of the COVID-19 pandemic response. However, on May 7 2024, the European Commission announced the vaccine is no longer authorised for use. The first ...
FRANKFURT (Reuters) – A study of side effects following vaccination with AstraZeneca’s anti-COVID-19 shot in Scotland found only an association with a largely harmless bleeding condition and no link ...
A new analysis examined deaths in Britain, where the company’s product was restricted in 2021 because of safety concerns. By Apoorva Mandavilli Young women who received at least one dose of the Covid ...
Regulatory Recon is our regular intelligence briefing for the regulatory affairs space, bringing you the top regulatory, biopharma and medtech news stories from around the globe. Regulatory Recon is ...
European regulators are set to start an accelerated review of a Covid-19 vaccine front-runner from the University of Oxford and AstraZeneca Plc, according to a person with knowledge of the situation, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results